Hematology/Oncology Research at Rutgers Cancer Institute

Andrew Evens, DO, MBA, MSc discusses research advances happening at Rutgers Cancer Institute of New Jersey.

The physicians and scientists at Rutgers Cancer Institute of New Jersey are nationally and internationally recognized cancer specialists engaged in translational research, which means they are committed to moving scientific discovery into clinical practice rapidly and efficiently.

Our blood cancer specialists focus on patients with acute and chronic leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, myelodysplasia, myeloproliferative diseases, and other hematologic malignancies in addition to benign blood disorders. They work together to provide the most effective and advanced treatments offered, many available only at NCI-designated Comprehensive Cancer Centers such as ours.

Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, earned several High Performing ratings in the 2023-2024 U.S. News & World Report Best Hospitals survey, including for leukemia, lymphoma & myeloma.